Company Overview of GelTex Pharmaceuticals, Inc.
As of December 14, 2000, GelTex Pharmaceuticals, Inc. was acquired by Genzyme Corp. GelTex Pharmaceuticals, Inc. is engaged in developing and marketing non-absorbed polymer drugs that bind and eliminate targeted substances within the gastrointestinal tract, as of September 30, 2000. In addition, GelTex is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators. Therapeutic areas of interest included hyperphosphatemia, hypercholesterolemia, cancer, iron overload, and infectious diseases. The company is based in Waltham Massachusetts.
153 Second Avenue
Waltham, MA 02451
Key Executives for GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|TrackFive Diagnostics, Inc.||United States|
|Oncobiologics, Inc.||United States|
|Everon Biosciences, Inc.||United States|
|Health Technology Networks||United States|
|Paradise Genomics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact GelTex Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.